Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI.

Published byJoel Kähkönen Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI."— Presentation transcript:

1 Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI.
Performance of the MGA to enable or enhance locomotor control after SCI. (A) Subjects with SCI walked overground without and with MGA using the least-assistive device possible. To quantify locomotor performance and identify the most relevant parameters, a PCA-based method has been applied, as described in fig. S3. On the right, the computed parameters that strongly correlated with a given PCA (|loading factors| > 0.5) were regrouped into functional clusters. Numbers refer to table S1. (B) Subjects were segregated into four categories: nonambulatory (wheelchair), walker, crutches, and none. Image and stick diagram decomposition of whole-body movements (and assistive device) are shown for each category and condition. (C) Plots reporting the mean values of locomotor performance and classic gait parameters for each subject during locomotion without and with MGA. The horizontal orange bars report the means ± SEM (thickness) measured during locomotion in healthy subjects. *P < 0.05, Wilcoxon signed-rank tests, n = 15 subjects with SCI. Jean-Baptiste Mignardot et al., Sci Transl Med 2017;9:eaah3621 Published by AAAS

Download ppt "Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI."

Similar presentations

Fig. 1 CSF1 is increased in blood of melanoma patients and correlates with disease progression. CSF1 is increased in blood of melanoma patients and correlates.

Fig. 1 CSF1 is increased in blood of melanoma patients and correlates with disease progression. CSF1 is increased in blood of melanoma patients and correlates.
Fig. 1. TP is highly expressed in myeloma.

Fig. 1. TP is highly expressed in myeloma.
Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.

Fig. 6. Sh-lantibiotics are commonly found on healthy human skin and synergize with a host AMP. Sh-lantibiotics are commonly found on healthy human skin.
Fig. 7. Gradient of adipocyte size and FAI around the human coronaries in the presence or absence of coronary atherosclerosis. Gradient of adipocyte size.

Fig. 7. Gradient of adipocyte size and FAI around the human coronaries in the presence or absence of coronary atherosclerosis. Gradient of adipocyte size.
Fig. 3. Copy number loss as a potential resistance mechanism in an independent cohort. Copy number loss as a potential resistance mechanism in an independent.

Fig. 3. Copy number loss as a potential resistance mechanism in an independent cohort. Copy number loss as a potential resistance mechanism in an independent.
Fig. 4. BET bromodomain inhibition suppresses transactivation of shared transcriptional networks across HF models. BET bromodomain inhibition suppresses.

Fig. 4. BET bromodomain inhibition suppresses transactivation of shared transcriptional networks across HF models. BET bromodomain inhibition suppresses.
Fig. 3. Design of the MGA algorithm.

Fig. 3. Design of the MGA algorithm.
Fig. 2. Interaction between upward and forward forces during standing and walking. Interaction between upward and forward forces during standing and walking.

Fig. 2. Interaction between upward and forward forces during standing and walking. Interaction between upward and forward forces during standing and walking.
Fig. 3 Urinary LAM concentration predicted pulmonary TB and correlated to mycobacterial burden and weight loss. Urinary LAM concentration predicted pulmonary.

Fig. 3 Urinary LAM concentration predicted pulmonary TB and correlated to mycobacterial burden and weight loss. Urinary LAM concentration predicted pulmonary.
Fig. 3. Structure of ALS-associated RNA binding proteins.

Fig. 3. Structure of ALS-associated RNA binding proteins.
Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.
Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.

Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
Fig. 4. Specific antibiotics reduce fecal biomass in mice and humans.

Fig. 4. Specific antibiotics reduce fecal biomass in mice and humans.
Fig. 4. Validation of MGA algorithm in individuals with SCI or stroke.

Fig. 4. Validation of MGA algorithm in individuals with SCI or stroke.
Fig. 1. Associations between fecal amino acids and their derivatives with disease in pediatric patients with Crohn’s disease compared to healthy subjects.

Fig. 1. Associations between fecal amino acids and their derivatives with disease in pediatric patients with Crohn’s disease compared to healthy subjects.
Fig. 4. Biomechanical properties of treated tibiae.

Fig. 4. Biomechanical properties of treated tibiae.
Fig. 2. Associations between bacterial taxa abundance ascertained by fecal shotgun metagenomic sequencing and the fecal metabolome in healthy pediatric.

Fig. 2. Associations between bacterial taxa abundance ascertained by fecal shotgun metagenomic sequencing and the fecal metabolome in healthy pediatric.
Fig. 1 Crohn’s disease association within the LRRK2 locus.

Fig. 1 Crohn’s disease association within the LRRK2 locus.
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.

Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.

Similar presentations

Ads by Google